Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care

✍ Scribed by Bandelow, Borwin (author);Sher, Leo (author);Bunevicius, Robertas (author);Hollander, Eric (author);Kasper, Siegfried (author);Zohar, Joseph (author);Möller, Hans Jürgen (author);Thibaut, Florence (author);Baranska-Rybak, Wioletta (author);Cubala, Wieclaw J. (author);Fiellin, David (author);Kranzler, Henry R. (author);Moore, Alison (author);Rankans, Elmars (author);Rasmussen, Jill (author);Saitz, Richard (author);Saravane, Djea (author);Schlaepfer, Thomas E. (author);Tang, S. W. (author);Valius, Leonas (author);Wong, David (author);Zhitnikova, Larisa M. (author);Allgulander, C. (author);Ayuso-Gutierrez, J. (author);Baldwin, D. (author);Bunevicius, R. (author);Cassano, G. (author);Fineberg, N. (author);Gabriels, L. (author);Hindmarch, I. (author);Kaiya, H. (author);Klein, D. F. (author);Lader, M. (author);Lecrubier, Y. (author);Lepine, J. P. (author);Liebowitz, M. R. (author);Lopez-Ibor, J. J. (author);Marazitti, D. (author);Miguel, E. C. (author);Oh, K. S. (author);Preter, M. (author);Rupprecht, R. (author);Sato, M. (author);Starcevic, V. (author);Stein, D. J. (author);Van Ameringen, M. (author);Vega, J. (author)

• Book ID: 120235746
• Publisher: Informa plc
• Year: 2012
• Tongue: English
• Weight: 98 KB
• Volume: 16
• Category: Article
• ISSN: 1365-1501
• DOI: 10.3109/13651501.2012.667114

✦ Synopsis

Objective. Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners. Methods. This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessive -compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) for the treatment in primary care. The recommendations were developed by a task force of 30 international experts in the fi eld and are based on randomized controlled studies. Results. First-line pharmacological treatments for these disorders are selective serotonin reuptake inhibitors (for all disorders), serotonin-norepinephrine reuptake inhibitors (for some) and pregabalin (for generalized anxiety disorder only). A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy. Conclusions. This short version of an evidence-based guideline may improve treatment of anxiety disorders, OCD, and PTSD in primary care.